Wednesday, November 14, 2018


Banner Content
Rep. Christopher Collins (R-NY) departs the Thurgood Marshall United States Courthouse following his arraignment on insider trading charges in New York, August 8, 2018. 

Lucas Jackson | Reuters
Rep. Christopher Collins (R-NY) departs the Thurgood Marshall United States Courthouse following his arraignment on insider trading charges in New York, August 8, 2018. 

Rep. Chris Collins, the Republican recently indicted on federal insider trading charges, will retain his House seat representing New York’s 27th District, NBC News has projected.

He is accused of tipping off son Cameron about a failed drug trial by the Australian pharmaceuticals company Innate Immunotherapeutics. The congressman was serving on the company’s board at the time. Cameron Collins then allegedly sold his shares, before news of the drug trial became public and sent the price of the stock tumbling.

Chris Collins has pleaded not guilty to the charges.

Collins’ district strongly supported Trump in the 2016 presidential election. Trump won there by 24.5 percentage points.

0 Comments

Leave a Comment

Advertisement

Predator 21 x